<DOC>
	<DOCNO>NCT00012168</DOCNO>
	<brief_summary>RATIONALE : New image procedure lymphoscintigraphy may improve ability detect spread mouth throat cancer lymph node neck . PURPOSE : Pilot study lymphoscintigraphy follow sentinel lymph node mapping sentinel lymph node biopsy detect lymph node metastasis neck patient mouth throat cancer .</brief_summary>
	<brief_title>Lymphoscintigraphy Detect Early Metastases Patients With Cancer Mouth Throat</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate sensitivity lymphoscintigraphy isosulfan blue localization sentinel lymph nodes patient previously untreated squamous cell carcinoma oral cavity oropharynx . - Determine evidence micrometastases histologically normal sentinel lymph node resect patient . - Assess clinical significance micrometastases lymph node resect patient . OUTLINE : Patients undergo preoperative lymphoscintigraphy utilize technetium Tc 99m sulfur colloid follow intraoperative injection isosulfan blue 3-4 location primary tumor periphery . Once afferent lymphatic channel sentinel node identify , patient undergo cervical lymphadenectomy follow resection primary tumor . Resected primary tumor , radioactive lymph node , blue-stained sentinel node subject molecular ( polymerase chain reaction ) histocytochemical ( immunohistochemistry cytokeratin micrometastases , light microscopy ) analyse . Patients follow 1 , 3 , 6 , 12 , 18 , 24 month . PROJECTED ACCRUAL : Approximately 25 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary squamous cell carcinoma oral cavity oropharynx Stage 0IVA ( Any T , N0 ) No lowrisk tumor Must require elective staging neck dissection resection primary tumor PATIENT CHARACTERISTICS : Age : 18 70 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant nursing No concurrent impair mental status PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics No prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>stage 0 oropharyngeal cancer</keyword>
	<keyword>stage 0 lip oral cavity cancer</keyword>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
</DOC>